Blog
RSS FeedPosted by Michael Wonder on 28 Aug 2018
Pfizer calls for FDA guidance to address false and misleading biosimilar advertisements
28 August 2018 - Taking issue with Amgen, Genentech and other reference product sponsors’ dissemination of misleading information on biosimilars, ...
Posted by Michael Wonder on 23 Aug 2018
FDA adds four tropical diseases to priority review voucher program to encourage drug development in areas of unmet need
23 August 2018 - Today, the U.S. FDA announced the addition of Lassa fever, chikungunya virus disease, rabies and cryptococcal meningitis ...
Posted by Michael Wonder on 20 Aug 2018
Companies report no signs of drug makers cutting prices, despite Trump pledge
17 August 2018 - Several companies that manage prescription drug benefits for insurers say they have not received any commitments ...
Posted by Michael Wonder on 19 Aug 2018
States rush to rein in prescription costs, and drug companies fight back
18 August 2018 - States around the country are clamping down on pharmaceutical companies, forcing them to disclose and justify ...
Posted by Michael Wonder on 18 Aug 2018
CVS’s drug price plan lets pharma off too easy
18 August 2018 - A new program aimed at keeping costs down allows too many expensive treatments to slip through. ...
Posted by Michael Wonder on 01 Aug 2018
FDA supports critical research to spur innovation for continuous manufacturing technology to support and advance drug and biologics development
1 August 2018 - We know that novel manufacturing technologies for both small-molecule drugs and biological products have great potential to ...
Posted by Michael Wonder on 26 Jul 2018
Drug companies can’t game paediatric drug laws anymore
26 July 2018 - Drug companies can’t avoid including kids in certain clinical studies now that the FDA has finally ...
Posted by Michael Wonder on 23 Jul 2018
Pricing pledges from drug makers include plenty of fine print
23 July 2018 - Over the past two weeks, several large drug makers have either halted or rolled back prices ...
Posted by Michael Wonder on 20 Jul 2018
Trump's drug plan picks up momentum as Merck lowers some prices
19 July 2018 - Rebates, biosimilar competition, drug imports get priority. ...
Posted by Michael Wonder on 20 Jul 2018
Trump thanks Novartis, Pfizer for not raising drug prices
19 July 2018 - The president also said his administration was working toward substantially cutting prescription-drug prices. ...
Posted by Michael Wonder on 20 Jul 2018
Novartis joins Pfizer in holding line on drug prices in U.S.
18 July 2018 - Swiss drug maker says cost of drugs must relate to value. ...
Posted by Michael Wonder on 13 Jul 2018
FDA budget matters: investing in advanced domestic manufacturing
13 July 2018 - There’s new technology that can improve drug quality, address shortages of medicines, lower drug costs, and bring ...
Posted by Michael Wonder on 12 Jul 2018
The drug pricing playbook: how pharma companies keep costs high
12 July 2018 - Pfizer faced presidential fire for its price rises but others use more subtle tactics. ...
Posted by Michael Wonder on 12 Jul 2018
Pharmaceutical companies ignore Donald Trump and raise drug prices
13 July 2018 - US President Donald Trump bragged may have bragged about convincing Pfizer to hold off on price ...
Posted by Michael Wonder on 12 Jul 2018
Top Democrats demands more details on pricing deal between Pfizer and Trump
11 July 2018 - The top Democrat on the Senate Finance Committee is demanding details on an agreement between President ...